141 related articles for article (PubMed ID: 8461921)
1. Anti-P antibodies are associated with psychiatric and focal cerebral disorders in patients with systemic lupus erythematosus.
Teh LS; Hay EM; Amos N; Black D; Huddy A; Creed F; Bernstein RM; Holt PJ; Williams BD
Br J Rheumatol; 1993 Apr; 32(4):287-90. PubMed ID: 8461921
[TBL] [Abstract][Full Text] [Related]
2. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus.
Schneebaum AB; Singleton JD; West SG; Blodgett JK; Allen LG; Cheronis JC; Kotzin BL
Am J Med; 1991 Jan; 90(1):54-62. PubMed ID: 1986591
[TBL] [Abstract][Full Text] [Related]
3. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
Hirohata S; Arinuma Y; Takayama M; Yoshio T
Arthritis Res Ther; 2007; 9(3):R44. PubMed ID: 17472755
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to protein P in systemic lupus erythematosus.
Teh LS; Bedwell AE; Isenberg DA; Gordon C; Emery P; Charles PJ; Harper M; Amos N; Williams BD
Ann Rheum Dis; 1992 Apr; 51(4):489-94. PubMed ID: 1586246
[TBL] [Abstract][Full Text] [Related]
5. Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity.
Jarpa E; Babul M; Calderón J; González M; Martínez ME; Bravo-Zehnder M; Henríquez C; Jacobelli S; González A; Massardo L
Lupus; 2011 Jan; 20(1):58-66. PubMed ID: 21078764
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric manifestations in patients with systemic lupus erythematosus: diagnostic and predictive value of longitudinal examination of anti-ribosomal P antibody.
Watanabe T; Sato T; Uchiumi T; Arakawa M
Lupus; 1996 Jun; 5(3):178-83. PubMed ID: 8803887
[TBL] [Abstract][Full Text] [Related]
7. Neurological involvement in systemic lupus erythematosus.
McLean BN
Curr Opin Neurol; 1998 Jun; 11(3):247-51. PubMed ID: 9642544
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies.
Nery FG; Borba EF; Viana VS; Hatch JP; Soares JC; Bonfá E; Neto FL
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):695-700. PubMed ID: 18077068
[TBL] [Abstract][Full Text] [Related]
9. Cognitive impairment and autoantibodies in systemic lupus erythematosus.
Hanly JG; Walsh NM; Fisk JD; Eastwood B; Hong C; Sherwood G; Jones JV; Jones E; Elkon K
Br J Rheumatol; 1993 Apr; 32(4):291-6. PubMed ID: 8461922
[TBL] [Abstract][Full Text] [Related]
10. Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus.
Isshi K; Hirohata S
Arthritis Rheum; 1996 Sep; 39(9):1483-90. PubMed ID: 8814059
[TBL] [Abstract][Full Text] [Related]
11. A close temporal relationship of liver disease to antiribosomal P0 protein antibodies and central nervous system disease in patients with systemic lupus erythematosus.
Yoshio T; Masuyama JI; Minota S; Kaneko N; Iwamoto M; Okazaki H; Mimori A; Takeda A; Kano S
J Rheumatol; 1998 Apr; 25(4):681-8. PubMed ID: 9558169
[TBL] [Abstract][Full Text] [Related]
12. Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus.
Massardo L; Bravo-Zehnder M; Calderón J; Flores P; Padilla O; Aguirre JM; Scoriels L; González A
Lupus; 2015 May; 24(6):558-68. PubMed ID: 25318968
[TBL] [Abstract][Full Text] [Related]
13. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
14. Cerebral disease in systemic lupus erythematosus.
Harris EN; Hughes GR
Springer Semin Immunopathol; 1985; 8(3):251-66. PubMed ID: 3901369
[No Abstract] [Full Text] [Related]
15. The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease.
Tzioufas AG; Tzortzakis NG; Panou-Pomonis E; Boki KA; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM
Ann Rheum Dis; 2000 Feb; 59(2):99-104. PubMed ID: 10666163
[TBL] [Abstract][Full Text] [Related]
16. [Central neuropsychiatric involvement in systemic lupus erythematosus].
Madrane S; Ribi C
Rev Med Suisse; 2012 Apr; 8(337):848-53. PubMed ID: 22594009
[TBL] [Abstract][Full Text] [Related]
17. Psychiatric disorder and cognitive impairment in systemic lupus erythematosus.
Hay EM; Black D; Huddy A; Creed F; Tomenson B; Bernstein RM; Holt PJ
Arthritis Rheum; 1992 Apr; 35(4):411-6. PubMed ID: 1567490
[TBL] [Abstract][Full Text] [Related]
18. [Neuropsychiatric symptoms and findings in systemic lupus erythematosus ].
Lund C; Gjerstad L
Tidsskr Nor Laegeforen; 1997 May; 117(14):2043-5. PubMed ID: 9235685
[TBL] [Abstract][Full Text] [Related]
19. Quantification of antiribosomal P0 protein antibodies by ELISA with recombinant P0 fusion protein and their association with central nervous system disease in systemic lupus erythematosus.
Yoshio T; Masuyama J; Ikeda M; Tamai K; Hachiya T; Emori T; Mimori A; Takeda A; Minota S; Kano S
J Rheumatol; 1995 Sep; 22(9):1681-7. PubMed ID: 8523345
[TBL] [Abstract][Full Text] [Related]
20. The neuropsychiatric disorder in systemic lupus erythematosus: evidence for both vascular and immune mechanisms.
Bresnihan B; Hohmeister R; Cutting J; Travers RL; Waldburger M; Black C; Jones T; Hughes GR
Ann Rheum Dis; 1979 Aug; 38(4):301-6. PubMed ID: 496443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
